Point72 Asia (Singapore)’s Caribou Biosciences CRBU Stock Holding History

Point72 Asia (Singapore)’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$69.1K	Sell	29,658 -29,880	-50%	-$56.4K	0.01%	509
2025 Q2	$75K	Buy	+59,538	New	+$58.6K	0.01%	523
2025 Q1	–	Sell	-19	Closed	-$30	–	929
2024 Q4	$30	Sell	19 -2	-10%	-$4	﹤0.01%	829
2024 Q3	$42	Sell	21 -31,810	-100%	-$65.1K	﹤0.01%	908
2024 Q2	$52.2K	Buy	+31,831	New	+$102K	0.01%	643

Other funds holding CRBU

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Point72 Asia (Singapore)'s CRBU Position: Q3 2025 in Review

Point72 Asia (Singapore) reduced its Caribou Biosciences (CRBU) stake by 50% in Q3 2025, selling an estimated $56.4K and leaving 29,658 shares worth $69.1K. The position accounts for 0.01% of the portfolio, ranked #509.

Point72 Asia (Singapore) first reported a position in CRBU in Q2 2024 and has held it in 5 quarters since. The position peaked at $75K in Q2 2025. 117 funds tracked by Wall St. Rank hold CRBU as of Q3 2025.

Point72 Asia (Singapore) held 29,658 shares of Caribou Biosciences worth $69.1K as of Q3 2025.
Point72 Asia (Singapore) sold 29,880 Caribou Biosciences shares in Q3 2025, an estimated $56.4K.
Caribou Biosciences made up 0.01% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #509 holding.
Point72 Asia (Singapore) first reported a position in Caribou Biosciences in Q2 2024 and has held it in 5 quarters since.
Point72 Asia (Singapore)'s Caribou Biosciences position peaked at $75K in Q2 2025.
117 funds tracked by Wall St. Rank held Caribou Biosciences as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.